Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | AB-16B5 |
Trade Name | |
Synonyms | AB 16B5|AB16B5 |
Drug Descriptions |
AB-16B5 is a monoclonal antibody that binds to and inhibits the activity of human clusterin (sCLU), resulting in inhibition of tumor cell proliferation and metastasis (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C121778 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
AB-16B5 | AB-16B5 | 0 | 1 |
AB-16B5 + Docetaxel | AB-16B5 Docetaxel | 0 | 1 |
AB-16B5 + Fluorouracil + Leucovorin + Oxaliplatin | AB-16B5 Fluorouracil Leucovorin Oxaliplatin | 0 | 1 |